New approaches to the management of fibroids.
New and innovative treatments are available for the control of uterine leiomyomata, each with advantages and disadvantages. Most of these techniques have few data to support their use; they are generally poorly studied, with brief follow-up. Not much is known regarding risks, costs, and comparative value. Furthermore, many of these procedures are in a state of evolution, with current investigative results having little applicability to the future use of such tools. Given the increasing number of options available to the patient with fibroids, further investigation is needed. A series of high-quality, randomized, comparative trials are needed to assess the relative merits of these new alternatives to treatment.
Olive
D L
DL
Department of Obstetrics and Gynecology, Baylor University Medical Center, Dallas, Texas, USA.
D004621:Embolization, Therapeutic; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D006801:Humans; D007044:Hysterectomy / Q000379:methods; D010535:Laparoscopy / Q000379:methods; D007889:Leiomyoma / Q000601:surgery* / Q000628:therapy; D009215:Myometrium / Q000601:surgery; D014594:Uterine Neoplasms / Q000601:surgery* / Q000628:therapy
D007987:Gonadotropin-Releasing Hormone